WebCytoxan and Liver injury - a phase IV clinical study of FDA data Summary: Liver injury is found among people who take Cytoxan, especially for people who are male, 40-49 old, have been taking the drug for < 1 month. The phase IV clinical study analyzes which people take Cytoxan and have Liver injury. WebCytoxan (cyclophosphamide) is a cancer (chemotherapy) medication used alone to treat breast cancer, leukemia, ovarian cancer, and nephrotic syndrome (a disease of the …
UPLC-Q-TOF/MS-based metabolomics reveals modulatory effects of
WebCyclophosphamide, also called Cytoxan, is classified as a “cytotoxic agent”, because it has a toxic effect on many types of cells (“good” cells as well as “bad”). … WebCyclophosphamide ( CP ), also known as cytophosphane among other names, [3] is a medication used as chemotherapy and to suppress the immune system. [4] As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma. [4] def thinking
Systemic Lupus Erythematosus: Diagnosis and Treatment AAFP
WebSep 18, 2024 · Check with your doctor immediately if any of the following side effects occur while taking cyclophosphamide: More common Cough or hoarseness fever or chills … WebCyclophosphamide/Top otecan Cyclophosphamide Topotecan N/A 22 DOXOrubicin/CISplatin DOXOrubicin CISplatin Both as CIVI; compatible via Y-site 23 Etoposide/Ifosfamide Etoposide Ifosfamide Mesna given around ifosfamide administration 22 Gemcitabine/DOCEtaxel Gemcitabine DOCEtaxel N/A 24 ... WebCyclophosphamide: Lupus nephritis, severe SLE: ... Complete blood count and liver function testing at baseline, then every one to two weeks at initiation of therapy, then one … def tholos